Dose Accuracy: When Every Millilitre Matters

Precision Feeding and Medication Delivery in the Smallest and Sickest Patients

In neonatal care, the difference between 0.1 mL and 0.2 mL is not trivial, it can be life‑changing.
Neonates, especially extremely low‑birth‑weight infants (ELBW), receive both nutrition and medications in extraordinarily small quantities. Their entire daily intake – nutritional, medicinal, and supplemental – depends on devices capable of exceptional micro‑precision.

Feeding volumes, medication doses, and fortifier additions must be exact. A slight deviation can compromise growth, destabilise physiology, or introduce serious side effects. Yet the tools clinicians depend on may not always be optimised for this level of accuracy.

This article explores the deep interplay between nutritional precision, medication dosing, device engineering, and clinical safety, drawing on international standards that explicitly warn of risks for neonatal patients.

Neonatal Dose Accuracy Is Clinically Non‑Negotiable

Neonates tolerate almost zero variability. A 500 g infant may receive feeds of 0.5 mL or medications as low as 0.1 mL or even 0.01 mL. There is no margin for error because:

• Underfeeding slows growth and prolongs dependence on parenteral nutrition.
• Overfeeding risks aspiration, reflux‑related apnoea, feeding intolerance, and abdominal distension.
• Underdosing medications makes them ineffective.
• Overdosing medications can cause severe harm, especially with high‑risk drugs like caffeine citrate, morphine, sedatives, electrolytes, and antibiotics.

Precision must therefore be guaranteed, not hoped for.

Device Limitations Amplify Dosing Risk

Even with expert technique, several factors undermine accurate delivery of both feeds and medications:

Dead space in connectors and tubing

High‑dead‑volume components can hold a significant portion of a neonatal dose, sometimes more than the dose itself.

Fluid displacement during connector engagement

Twisting two connectors together can physically expel fluid out of the syringe tip. This phenomenon is not theoretical; investigations have shown it to be real and clinically meaningful.

Surface adhesion of fluids

Milk, medications, and fortified feeds can cling to internal surfaces, reducing delivered amounts.

Flow instability at low rates

Many pumps struggle to maintain smooth, accurate delivery at 0.1–1.0 mL/hr.

Clinicians often compensate with workarounds, but these cannot eliminate the risks created by equipment design.

ISO 80369‑3: International Warnings About Accuracy Risks in Neonates

The International Standards Organisation (ISO) explicitly recognises the accuracy risks associated with certain connector geometries in neonatal care.

Following laboratory investigations, ISO added a critical warning in Annex A of ISO 80369‑3, highlighting the dangers of inverted (female‑to‑male) ENFit® connections:

“Concerns have been expressed about the possible risks associated with inaccurate drug delivery in certain clinical practices on high‑risk subpopulations, such as neonatal patients, when using an inverted (female to male) connection system. Such an orientation may cause accidental displacement of fluid originally contained in the […] syringe tip.”
— ISO 80369‑3, Annex A

ISO goes on to emphasise the implications for neonates receiving very small medication volumes:

“In a 500 g premature infant, enteral medications are often prescribed in very low dosages, in the range of 0.1 ml or even 0.01 ml.”
— ISO 80369‑3:2016

Yet laboratory tests showed that:

“A pair of medium tolerance [ENFit™] connectors coupled in a female-to-male orientation displaces an average fluid volume of 0.148 ml […].”
— ISO 80369‑3

This 0.148 mL displacement represents:

• 148% of a 0.1 mL neonatal medication dose, or
• 1,480% of a 0.01 mL dose

This means that the fluid lost from the connector alone can exceed the intended dose by an order of magnitude.

The standard explicitly identifies this as a risk for both medication accuracy and feeding accuracy.

Excessive Dead Volume: A Critical Issue for Medication Delivery

ISO also warns about excess fluid accumulation inside ENFit® connector cavities, noting:

“Excess fluid accumulated in the ENFit™ connector can be problematic in a neonatal patient, where the dosages of solutions, and especially of drugs administered, are very low.”
— ISO 80369‑3, Annex A

This has two immediate consequences:

1. Too little medication is delivered

Some fluid remains trapped in the connector rather than reaching the infant.

2. Too much may be delivered later

During a subsequent flush, residual high‑risk medication may be inadvertently pushed into the infant all at once, causing:

• bradycardia
• hypotension
• neurological effects
• oversedation
• electrolyte imbalance

For neonates, the difference between therapeutic and toxic doses can be extremely small.

Feeding Accuracy Is Also Impacted

The same issue applies to nutritional dosing:

• A 0.148 mL loss significantly affects a 0.5 mL trophic feed.
• Residual milk held in connector threads can alter caloric delivery.
• Flow irregularities create inconsistent gastric tolerance.
• Fortifiers magnify viscosity and flow variability.

Because growth is strongly correlated with early, accurate caloric delivery, even small deviations can influence developmental outcomes.

In short:
Connector geometry can change the clinical trajectory of a preterm infant.

Engineering Solutions: What Neonatal Units Truly Need

Devices intended for neonatal feeding and medication administration must be designed for:

True micro‑dosing precision

Graduated syringes with sub‑0.1 mL accuracy
Low‑residual connectors
Smooth pump operation at <1 mL/hr

Minimal dead space

Tubing and connectors engineered to reduce retention volume dramatically.

No fluid displacement during connection

Connector mechanics must prevent solutions from being inadvertently expelled.

Reduced need for manual compensation

Clinicians should not need to “overfill,” flush creatively, or adjust flow to achieve precision.

Safe use with high‑risk medications

System design must protect against variability that could cause overdose or underdose.

Support for feeding AND medication accuracy simultaneously

Because neonates receive medications enterally, systems must be optimised for both.

Precision Without Burden: Supporting the Clinician

Neonatal nurses care for infants whose lives hinge on details measured in hundredths of a millilitre.
They should not have to fight equipment to achieve the precision required.

Clinicians should never have to choose between dose accuracy, safety, and workflow efficiency. The device should protect all three.

The future of neonatal feeding and medication delivery lies in systems designed for the realities of neonatal care, not retrofits of adult technologies.

Next article:

References

1. International Organization for Standardization (ISO). ISO 80369‑3: Small‑bore connectors for liquids and gases in healthcare applications – Part 3: Enteral applications. Geneva: ISO; 2016.
2. International Organization for Standardization (ISO). ISO 80369‑3:2016. Annex A – Subpopulations in enteral clinical application. Geneva: ISO; 2016.
3. Koletzko B, Cheah F‑C, Domellöf M, Poindexter BB, Vain N, van Goudoever JB. Nutritional Care of Preterm Infants: Scientific Basis and Practical Guidelines. World Rev Nutr Diet. 2021;122:265‑280.
4. Embleton ND, Moltu SJ, Lapillonne A, van den Akker CHP, Carnielli V, Fusch C, et al. Enteral Nutrition in Preterm Infants: A Position Paper from the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2022;75(3):1‑29.
5. Cobb BA, Carlo WA, Ambalavanan N. Gastric residuals and their relationship to necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2004;113(1 Pt 1):50‑53.
6. Dorling J, Abbott J, Berrington J, Bowler U, Boyle E, Burton P, et al. Controlled trial of two incremental milk‑feeding rates in preterm infants. N Engl J Med. 2019;381(15):1434‑1443.
7. British Association of Perinatal Medicine (BAPM). Optimising Maternal Breast Milk for Preterm Infants: A Quality Improvement Toolkit. London: BAPM; 2020.